Simplified Post-Exposure Prophylaxis for Previously Vaccinated Pregnant Patients
A pregnant patient who has previously completed a primary rabies vaccination series should receive only 2 doses of rabies vaccine (1.0 mL IM on days 0 and 3) without rabies immunoglobulin (RIG). 1, 2
Vaccination Protocol
For previously immunized persons (including pregnant women), the post-exposure regimen is straightforward:
- Day 0: Administer 1.0 mL rabies vaccine IM in the deltoid area immediately after exposure
- Day 3: Administer second 1.0 mL dose IM in the deltoid area
- No RIG: Rabies immunoglobulin should NOT be administered 1, 2
This applies to anyone with documented history of:
- Complete pre-exposure prophylaxis with cell culture vaccine (HDCV, PCECV, or RVA)
- Prior post-exposure prophylaxis with cell culture vaccine
- Previous vaccination with documented antibody response 1
Wound Management
Regardless of vaccination status, all post-exposure prophylaxis must begin with:
- Immediate thorough wound cleansing with soap and water for approximately 15 minutes
- Application of virucidal agent (e.g., povidone-iodine solution) if available 1, 2
Safety in Pregnancy
Rabies vaccination during pregnancy is safe and should never be withheld due to pregnancy status. Multiple studies confirm:
- No moderate or severe adverse effects in pregnant women receiving rabies PEP 3
- No congenital malformations or developmental abnormalities in infants 3, 4, 5
- Normal intrauterine growth and satisfactory pregnancy outcomes 4
- Protective antibody levels achieved comparable to non-pregnant individuals 4
The evidence from 72 pregnant women followed through delivery showed normal infant development in all cases, with only expected background rates of pregnancy complications 3. Given rabies' 100% fatality rate once symptomatic, pregnancy is absolutely not a contraindication to post-exposure prophylaxis 6, 7.
Critical Caveat
If the patient's immune status is uncertain or they did not receive the recommended cell culture vaccine regimen, full primary post-exposure treatment (RIG plus 4-5 doses of vaccine) may be necessary 2. However, if pre-vaccination serology demonstrates antibody levels >1:5 dilution by RFFIT, treatment can be discontinued after at least 2 doses 2.